: A proportion of patients with severe asthma treated with biological drugs undergoes a significant decline in F ENO. However, variations in F ENO are largely independent of the clinical efficacy of the biological drug therapy. https://bit.ly/3xWszYJ.
Revealing the gap: fractional exhaled nitric oxide and clinical responsiveness to biological therapy in severe asthma – a retrospective study / Maniscalco, Mauro; Candia, Claudio; Visca, Dina; D'Amato, Maria; Calabrese, Cecilia; Ambrosino, Pasquale; Molino, Antonio; Fuschillo, Salvatore. - In: ERJ OPEN RESEARCH. - ISSN 2312-0541. - 10:5(2024), pp. 00296-2024. [10.1183/23120541.00296-2024]
Revealing the gap: fractional exhaled nitric oxide and clinical responsiveness to biological therapy in severe asthma – a retrospective study
Maniscalco, Mauro;Candia, Claudio;Ambrosino, Pasquale;Molino, Antonio;
2024
Abstract
: A proportion of patients with severe asthma treated with biological drugs undergoes a significant decline in F ENO. However, variations in F ENO are largely independent of the clinical efficacy of the biological drug therapy. https://bit.ly/3xWszYJ.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
